Crowdonomics
CBD Life Sciences Inc.

Reg A+ · Equity · Jun 2026

OpenReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $448K max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2025 · hover for source
$98K
−$43K
FY2025
RevenueNet income
Metric
FY2025 audited
Income statement
Revenue
$98,321
Cost of goods sold
$141,760
Gross margin
-44%
Net income
-$43,439
Balance sheet
Cash
$331,598
Accounts receivable
$250,760
Total assets
$787,233
Long-term debt
$0
Total liabilities
$38,505
Other
Headcount
3

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Est. pre-money$576.3K
Price / share$0.0001
Shares offered4,000,000,000

Estimated, not stated: $0.0001 × 5,763,080,257 securities outstanding.

Down round. Priced 100% below Reg A Offering (2022) (Aug 2022) on a split-adjusted basis: $0.0001 vs $0.09 a share in today's terms — a conversion or split sits between the two, so check its ratio on the earlier round.

Offering details

Target—
Max$448,000
Min investment—
OpenedJun 8, 2026
Deadline—
Days active123

Links & provenance

Source: SEC EDGAR
0001683168-26-004020
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.